Skip to main content
SpringerLink
Log in

Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain

  • Drug Information
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Governments concerned with the rising cost of pharmaceuticals are striving to promote the use of generic drugs. To develop nonmature markets, demand-side policies are essential in considering the consumer’s active role in the decision-making process. Our model studies the causal relationships influencing consumer purchase intention, including perceived risk, experience, and information provided by a physician and pharmacist as antecedents. The main results of a survey of 560 individuals indicate that perceived risk and experience directly influence the purchase motivation. Experience reduces the risk and physicians’ advice slightly increases perceived risk. Market developers of generic drugs should coordinate strategies to include the 3 agents involved (physicians, pharmacists, and consumers) to decrease perceived risk and thereby increase consumer trust in generic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yelkur R. Consumer perceptions of generic products: a Mexican study. J Prod Brand Manage. 2000;9(7):446–456.

    Article  Google Scholar 

  2. Sheppard A. Generic medicines: essential contributors to the long-term health society. IMS Health. 2010. https://doi.org/www.imshealth.com/imshealth/Global/Content/Document/Market_Measurement_TL/Generic_Medicines_GA.pdf

  3. Aeseg. Workshop Periodistas-Mercado Genéricos. 2010. https://doi.org/www.aeseg.es/IMS-AESEG%20Workshop%20Periodistas%20Nov2010.pdf. Accessed January 15, 2011.

  4. Aeseg. Genéricos en España. 2010. https://doi.org/www.aeseg.es/aeseg_genericos_en_espana.asp. Accessed January 15, 2011.

  5. Kravitz R, Bell R, Azari R, Kelly-Reif S, Krupat E, Thom D. Direct observation of requests for clinical services in office practice. Arch Intern Med. 2003;163(14):1663–1681.

    Article  Google Scholar 

  6. King D, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Med J. 2002;43(4):462–469.

    Google Scholar 

  7. Dholakia U. A motivational process model of product involvement and consumer risk perception. J Marketing. 2001;35(11-12):1340–1360.

    Google Scholar 

  8. Carroll NV, Wolfang A. Inherent risk and market acceptance of generic drug products. J Health Care Marketing. 1989;9(4):48–51.

    CAS  Google Scholar 

  9. Ogletorpe J, Monroe K. Determinants of perceived health and safety risks of selected hazardous products and activities. J Consumer Affairs. 1994;28(2):326–346.

    Article  Google Scholar 

  10. Carroll NV, Wolfang A. Risk, benefits and generic substitution. J Consumer Affairs. 1991;25(1):110–121.

    Article  Google Scholar 

  11. Carroll NV, Siridhara C, Fincham JE. Perceived risks and pharmacists’ generic substitution behaviour. J Consumer Affairs. 1986;20(1):36–47.

    Article  Google Scholar 

  12. Bearden W, Mason J. Consumer perceived risk and attitudes toward generically prescribed drugs. J Appl Psychol. 1978;63(6):741–747.

    Article  Google Scholar 

  13. González S, González C, Díaz AM. Intención de compra de medicamentos genéricos por parte de los usuarios de Asturias. Rev Esp Salud Publica. 2003;77(6):691–699.

    Google Scholar 

  14. Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consumer Res. 1980;7(1):14–23.

    Article  Google Scholar 

  15. Bearden W, Mason J. Determinants of physician and pharmacists’ support of generic drugs. J Consumer Res. 1980;7:121–130.

    Article  Google Scholar 

  16. Turnbull P, Parson N. Generic prescribing in general medical practice: an attitudinal study of general practitioners. Marketing Intell Plann. 1993;11(4):30–40.

    Article  Google Scholar 

  17. Mason J Bearden W. Generic drugs: consumer, pharmacist and physician perceptions of the issues. J Consumer Affairs. 1980;14(1):193–206.

    Article  Google Scholar 

  18. Tootelian DH, Gaedeke RM, Schlacter J. Branded versus generic prescription drugs: perception of risk, efficacy, safety and value. J Health Care Marketing. 1988;8(3):26–29.

    CAS  Google Scholar 

  19. Hellerstein J. The importance of the physician in the generic versus trade-name prescription decision. RAND J Econ. 1988;29(1):108–136.

    Article  Google Scholar 

  20. Cyryl de Run E, Ng Felix MN. Patented and generic pharmaceutical drugs: perception and prescription. Int J Business Soc. 2006;7(2):55–78.

    Google Scholar 

  21. Hassali MA, Kong DC, Steward K. Knowledge and perceptions of recent pharmacy graduates about generic medicines. Pharm Educ. 2007;7(1):89–95.

    Article  Google Scholar 

  22. Fisher M, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003;38(4):1051–1064.

    Article  Google Scholar 

  23. Aronsson T, Bergman M, Rudholm N. The impact of generic drug competition on brand name market-shares: evidence from micro data. Rev Ind Organ. 2001;19(4):425–435.

    Article  Google Scholar 

  24. Stone RN Grønhaug K. Perceived risk: further considerations for the marketing discipline. Eur J Marketing. 1993;27(3):39–50.

    Article  Google Scholar 

  25. Stone RN Mason JB. Attitude and risk: exploring the relationship. Psychol Marketing. 1995;12(2):135–153.

    Article  Google Scholar 

  26. Laroche M, McDougall GH, Bergeron J, Yang Z. Exploring how intangibility affects perceived risk. J Serv Res. 2004;4(4):373–389.

    Article  Google Scholar 

  27. Mourali M, Laroche M, Pons F. Antecedents of consumer relative preference for interpersonal information sources in pre-purchase search. J Consumer Behav. 2005;4(5):307–318.

    Article  Google Scholar 

  28. Park C, Mothersbaugh D Feick L. Consumer knowledge assessment. J Consumer Res. 1994;21(1):71–82.

    Article  Google Scholar 

  29. Agrawal M. Warning labels: the role of expertise and perceived risk in pharmaceutical purchase behaviour. Health Marketing Q. 1995;13(2):99–115.

    Article  Google Scholar 

  30. Allen J, Butler D. Assessing the effects of donor knowledge and perceived risk on intentions to donate blood. J Health Care Marketing. 1993;13(3):26–33.

    CAS  Google Scholar 

  31. Jöreskog KG Sörbom D. LISREL VI: Analysis of Linear Structure Relationships by the Method of Maximum Likelihood. Chicago: National Educational Resources; 1984.

    Google Scholar 

  32. Centenera JI. Importancia de los medicamentos genéricos en el control del gasto. In: López J, ed. Medicamentos genéricos. Pamplona, Spain: EUNSA; 2007:123–146.

    Google Scholar 

  33. Jarvis L. A generics boom could spell opportunity for API manufacturers. Chem Market Reporter. 2003;262(11):10–12.

    Google Scholar 

  34. Iñesta A. Genéricos: evolución y medidas que pueden favorecer el aumento de su prescripción y uso en el sistema Nacional de Salud. Economía de la Salud. 2010;7(3):106–110.

    Google Scholar 

  35. Simoens S, De Coster S. Sustaining Generic Medicines Markets in Europe. Leuven, Belgium: Research Centre for Pharmaceutical Care and Pharmacoeconomics, University of Leuven; 2006. https://doi.org/www.egagenerics.com/doc/simoens-report_2006-04.pdf. Accessed May 4, 2009.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Finance and Marketing Research, Faculty of Economic and Business Sciences, Universidad Autónoma de Madrid, Avda. Francisco Tomás y Valiente s/n, 28049, Cantoblanco, Madrid, Spain

    Mónica Gómez Assoc. Prof. & Mercedes Rozano Asst. Prof.

Authors
  1. Mónica Gómez Assoc. Prof.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mercedes Rozano Asst. Prof.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mónica Gómez Assoc. Prof..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez, M., Rozano, M. Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain. Ther Innov Regul Sci 46, 207–215 (2012). https://doi.org/10.1177/0092861511435907

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/0092861511435907

Keywords

Search

Navigation